mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.02 |